Startseite Development of an inverse-PCR approach for characterization of the major BCR-ABL1 breakpoint sequences on genomic DNA: proof of concept
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Development of an inverse-PCR approach for characterization of the major BCR-ABL1 breakpoint sequences on genomic DNA: proof of concept

  • Leandro G. Gutiérrez , Miguel M. Abelleyro , María Sol Ruiz , María Sol Anchordoqui , Josefina Freitas , Michele Bianchini , Carlos D. De Brasi und Irene B. Larripa EMAIL logo
Veröffentlicht/Copyright: 23. Juni 2021
Veröffentlichen auch Sie bei De Gruyter Brill

Received: 2020-10-06
Accepted: 2021-06-09
Published Online: 2021-06-23
Published in Print: 2021-11-25

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorials
  3. Optimizing effectiveness of COVID-19 vaccination: will laboratory stewardship play a role?
  4. Mathematical recalibration of total bile acids: comparing the incomparable?
  5. Reviews
  6. Could metabolomics drive the fate of COVID-19 pandemic? A narrative review on lights and shadows
  7. Low free-T3 serum levels and prognosis of COVID-19: systematic review and meta-analysis
  8. Opinion Paper
  9. Pancreatic lipase: why laboratory community does not take enough care of this clinically important test?
  10. General Clinical Chemistry and Laboratory Medicine
  11. The BACH project protocol: an international multicentre total Bile Acid Comparison and Harmonisation project and sub-study of the TURRIFIC randomised trial
  12. Comparability of 11 different equations for estimating LDL cholesterol on different analysers
  13. Streamlined three step total vitamin C analysis by HILIC-UV for laboratory testing
  14. Hematology and Coagulation
  15. Anti-phosphatidyl-serine/prothrombin antibodies (aPS/PT) in isolated lupus anticoagulant (LA): is their presence linked to dual test positivity?
  16. Cancer Diagnostics
  17. Consideration should be given to smoking, endometriosis, renal function (eGFR) and age when interpreting CA125 and HE4 in ovarian tumor diagnostics
  18. Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference
  19. Cardiovascular Diseases
  20. Identification of macrotroponin T: findings from a case report and non-reproducible troponin T results
  21. Diabetes
  22. Impact of optimizing pre-analytical phase on the diagnosis of gestational diabetes and related outcomes
  23. Infectious Diseases
  24. Daily monitoring of viral load measured as SARS-CoV-2 antigen and RNA in blood, IL-6, CRP and complement C3d predicts outcome in patients hospitalized with COVID-19
  25. Alternative detection of SARS-CoV-2 RNA by a new assay based on mass spectrometry
  26. Performance evaluation of an automated SARS-CoV-2 Ag test for the diagnosis of COVID-19 infection on nasopharyngeal swabs
  27. Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine
  28. Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign
  29. Letters to the Editors
  30. Effects of various pre-analytical conditions on blood-based biomarkers of Alzheimer’s disease
  31. Stability of lactate in venous blood gas and sodium fluoride-potassium oxalate plasma: a 6-year retrospective database analysis
  32. Validation of the Fujirebio Lumipulse G1200 aldosterone assay for measurements during adrenal venous sampling for primary hyperaldosteronism
  33. The new Roche Elecsys TSH assay conforms with current IFCC C-STFT standards
  34. Development of an inverse-PCR approach for characterization of the major BCR-ABL1 breakpoint sequences on genomic DNA: proof of concept
  35. Antiphospholipid antibodies quantification using ALBIA technology: how to define an optimal cutoff?
  36. Simultaneous occurrence of EDTA-dependent lymphoagglutination and agglutination of myeloid cells in a patient with chronic myelomonocytic leukemia
  37. NT-proBNP use in old patients and the impact of the selected threshold value: a big data analysis
  38. Congress Abstracts
  39. 53rd National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC – Laboratory Medicine)
Heruntergeladen am 11.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2020-1482/html
Button zum nach oben scrollen